Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-22,654
Closed -$981K 142
2025
Q1
$981K Sell
22,654
-4,346
-16% -$216K 0.33% 51
2024
Q4
$1.39M Buy
27,000
+500
+2% +$26.8K 0.45% 47
2024
Q3
$1.34M Hold
26,500
0.42% 47
2024
Q2
$1.01M Buy
26,500
+4,000
+18% +$156K 0.32% 53
2024
Q1
$942K Buy
+22,500
New +$876K 0.31% 57

Other funds holding LAZ

O'Brien Greene & Co's LAZ Position: Q2 2025 in Review

O'Brien Greene & Co sold out of Lazard (LAZ) in Q2 2025, closing a stake of 22,654 shares — an estimated $981K sold.

O'Brien Greene & Co first reported a position in LAZ in Q1 2024 and held it in 5 quarters. The position peaked at $1.39M in Q4 2024. 301 funds tracked by Wall St. Rank hold LAZ as of Q2 2025.

  • O'Brien Greene & Co reported no remaining Lazard position as of Q2 2025 after selling out during the quarter.
  • O'Brien Greene & Co sold 22,654 Lazard shares in Q2 2025, an estimated $981K.
  • O'Brien Greene & Co first reported a position in Lazard in Q1 2024 and held it in 5 quarters.
  • O'Brien Greene & Co's Lazard position peaked at $1.39M in Q4 2024.
  • 301 funds tracked by Wall St. Rank held Lazard as of Q2 2025.

Based on O'Brien Greene & Co's 13F filing for Q2 2025, filed 6 Aug 2025.